These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 29027133

  • 1. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
    Tran BN, Nguyen HT, Kim JO, Yong CS, Nguyen CN.
    Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
    [Abstract] [Full Text] [Related]

  • 2. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Wang F, Li L, Liu B, Chen Z, Li C.
    Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
    [Abstract] [Full Text] [Related]

  • 3. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery.
    Liu Y, Zhou C, Wang W, Yang J, Wang H, Hong W, Huang Y.
    Mol Pharm; 2016 Dec 05; 13(12):4209-4221. PubMed ID: 27796093
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y, Zhou C, Wei S, Yang T, Lan Y, Cao A, Yang J, Hou Y.
    Colloids Surf B Biointerfaces; 2018 Oct 01; 170():330-340. PubMed ID: 29936386
    [Abstract] [Full Text] [Related]

  • 5. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M, Emami J, Hassanzadeh F, Sadeghi H, Rostami M, Mohammadkhani H.
    Curr Drug Deliv; 2017 Oct 01; 14(8):1189-1200. PubMed ID: 28472908
    [Abstract] [Full Text] [Related]

  • 6. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J, Zhang J, Deng C, Meng F, Zhong Z.
    Biomacromolecules; 2016 Jul 11; 17(7):2367-74. PubMed ID: 27305935
    [Abstract] [Full Text] [Related]

  • 7. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
    Li J, Yin T, Wang L, Yin L, Zhou J, Huo M.
    Int J Pharm; 2015 Apr 10; 483(1-2):38-48. PubMed ID: 25655715
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
    Yu D, Li W, Zhang Y, Zhang B.
    Biomed Pharmacother; 2016 Oct 10; 83():1428-1435. PubMed ID: 27592131
    [Abstract] [Full Text] [Related]

  • 9. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y, Goltsche K, Cheng L, Xie F, Meng F, Deng C, Zhong Z, Haag R.
    Biomaterials; 2016 Apr 10; 84():250-261. PubMed ID: 26851390
    [Abstract] [Full Text] [Related]

  • 10. High paclitaxel-loaded and tumor cell-targeting hyaluronan-coated nanoemulsions.
    Kim JE, Park YJ.
    Colloids Surf B Biointerfaces; 2017 Feb 01; 150():362-372. PubMed ID: 27823852
    [Abstract] [Full Text] [Related]

  • 11. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
    Tran BN, Nguyen HT, Kim JO, Yong CS, Nguyen CN.
    Drug Dev Ind Pharm; 2017 Dec 01; 43(12):1952-1962. PubMed ID: 28724314
    [Abstract] [Full Text] [Related]

  • 12. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
    Pandey V, Gajbhiye KR, Soni V.
    Drug Deliv; 2015 Feb 01; 22(2):199-205. PubMed ID: 24467582
    [Abstract] [Full Text] [Related]

  • 13. Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.
    Campos J, Varas-Godoy M, Haidar ZS.
    Nanomedicine (Lond); 2017 Mar 01; 12(5):473-490. PubMed ID: 28181464
    [Abstract] [Full Text] [Related]

  • 14. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A, Shiri F, Keikha S, Majd MH.
    Colloids Surf B Biointerfaces; 2018 Nov 01; 171():150-158. PubMed ID: 30025377
    [Abstract] [Full Text] [Related]

  • 15. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
    Yang XY, Li YX, Li M, Zhang L, Feng LX, Zhang N.
    Cancer Lett; 2013 Jul 01; 334(2):338-45. PubMed ID: 22776563
    [Abstract] [Full Text] [Related]

  • 16. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F, Wang X, Xu X, Li M, Zhou J, Wang W.
    Eur J Pharm Sci; 2016 Sep 20; 92():11-21. PubMed ID: 27343697
    [Abstract] [Full Text] [Related]

  • 17. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS, Cho CW.
    J Pharm Pharmacol; 2013 Jan 20; 65(1):72-8. PubMed ID: 23215690
    [Abstract] [Full Text] [Related]

  • 18. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
    Bhatt H, Kiran Rompicharla SV, Ghosh B, Biswas S.
    Mol Pharm; 2019 Apr 01; 16(4):1541-1554. PubMed ID: 30817166
    [Abstract] [Full Text] [Related]

  • 19. Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis.
    Liu R, Xiao W, Hu C, Xie R, Gao H.
    J Control Release; 2018 May 28; 278():127-139. PubMed ID: 29630985
    [Abstract] [Full Text] [Related]

  • 20. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
    Lv Y, Xu C, Zhao X, Lin C, Yang X, Xin X, Zhang L, Qin C, Han X, Yang L, He W, Yin L.
    ACS Nano; 2018 Feb 27; 12(2):1519-1536. PubMed ID: 29350904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.